Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 May 2025 | Story Martinette Brits | Photo Kaleidoscope Studios
Prof Hendrik Swart
Prof Hendrik Swart from the UFS Department of Physics was recently recognised by the Golden Key Honour Society Southern Africa as one of South Africa’s 300 most influential leaders.

Prof Hendrik Swart from the University of the Free State (UFS) Department of Physics was recently honoured at the Golden Key Honour Society Southern Africa’s Black Tie Gala Event, held on 23 May 2025. The event celebrated 300 of South Africa’s most influential leaders across academia, industry, government, and the financial sector.

Prof Swart, who is an NRF B1-rated researcher and currently also holds the SARChI Research Chair in Solid-state Luminescent and Advanced Materials (2023-2027), described the recognition as both meaningful and affirming at this stage of his academic journey.

“Being recognised by such a prestigious organisation is a meaningful acknowledgment of my academic efforts and personal dedication,” he says. “It was a moment of validation and inspiration, reminding me that hard work truly pays off.”

While the exact selection criteria were not publicly detailed, the emphasis was placed on academic excellence, scholarship, and leadership.

This is not Prof Swart’s first recognition from the Golden Key Honour Society. In 2012, the UFS student chapter awarded him honorary membership for his contributions as a mentor and supervisor – an early nod to his lasting impact on student success.

“The student chapter here on campus gave me some recognition by awarding me honorary membership,” he recalled. “It meant a lot to me as a mentor.”

The gala itself offered more than accolades – it created a space for meaningful exchange. Prof Swart reflected warmly on reconnecting with one of his former students from the early 2000s, calling it a highlight of the evening.

Looking ahead, Prof Swart welcomed the society’s plans to continue this initiative across the country.

“This was the first time they had an event like this, but more are expected to follow. I see it as a good initiative to mingle with other sectors in South Africa.”

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept